Mobilization in Indian intensive care units: Where do we stand?
Sir, We read with the great interest the article by Rajesh Chawla et al. (2014) surveying the mobilization, analgesic, and sedative practises in Indian intensive care units (ICUs). [1] We appreciate the authors for the greater efforts in evaluating the intensive care practises at a larger scale. Though the response rate was poor (11%), the study paves way for utilization of several standardization procedures including therapeutic practises in ICUs. Especially the study has demonstrated mobilization practices in Indian ICUs.
Mobilization is a standard practice in western ICUs. Earlier research had elaborated effects of early mobilization in maintenance of muscle mass, thus preventing critical illness myoneuropathy, increasing functional capacity, early functional independence, early weaning, reduction of ventilator-associated pneumonia and critical illness, reduction of intensive care, and hospital stay, improving neuropsychiatric outcomes such as ICU delirium, reduction of caregiver stress, and health resource utilization. [2] [3] [4] [5] [6] [7] Western literature including meta-analysis and systematic reviews are available stating significant evidence in mobilization of critically ill patients. [2, 5, 7] In the article by Rajesh Chawla (2014), we are not surprised by the fact that out of 94% (614 physician responders), only 13% (90 physicians) were in favor of mobilizing critically ill patients with equipments (ventilators and tubes). [1] Western literature supports mobilization of intensive care patients with ventilators and assistive devices. [8, 9] Safety in mobilizing intensive care patients with ventilators and tubes are proved earlier. [10, 11] We disagree the author in holding only physician apprehension as responsible for poor mobilization practises in Indian ICUs. This may be due to lack of infrastructure, expertise training in handling mobile ventilators, and mobilizing aids, such as mechanical hoists (passive transfer using mechanical aids) , [12] lack of therapist's and nurse's knowledge of initiating and progressing early mobilization in ICU, criteria for termination of mobilization, screening for risk stratification during mobilization, knowledge about mobility aids, and safe handling techniques. [10, 11] New promising researches are put forward depicting the positive attitude of mobilizing patients in Indian ICUs in past few years. [13] [14] [15] We recommend future trials in elucidating the effects of early mobilization in intensive care outcomes in Indian medical pitch.
Apart from the study mentioned, limitation, such as the poor response rate poor responders, few other setbacks prevent from generalization of the study results in Indian clinical arena. [1] First, majority of the responders are age below 40 (59%) and ICU practising experience below 5 years (41%). Since this survey partially depends on the experience of the practising intensivists, the practise patterns elaborated in the study are questionable to certain extent. Second, the majority of the responders are from institutions with less than 20 ICU beds (77%). Though the bed strength falls within the standardization of Indian Society for Critical care medicine (ISCCM), the systematic mobilization program may not be implemented at ease within the constrained perimeter of the ICUS included in the present study. Further, the current survey could have inclusions of various ICUs such as cardiology, neurology, post-surgical and traumatic practice patterns differing between ICUs within an Insitution itself which may question the applicability of the results in Indian clinical arena.
Other than the above limitations, the study adds evidence to the current therapeutic practises, newer association between sedation and mobilization and neuropsychiatric outcomes such as delirium in Indian intensive care settings. We appreciate once again the authors for demonstrating lag of current ICU practices behind the standard guidelines of therapeutic applications in Indian ICUs.
Sir,
Hyponatremia is the most common disorder of body fluid and electrolyte balance encountered in clinical critically ill patients and associated with increased morbidity and mortality. A wide range of conditions can cause hyponatremia and, as a result, it is being managed by clinicians from a variety of backgrounds with a variety of approaches to its diagnosis and management. Adding to the complexity is the available treatment options, which includes normal saline, hypertonic saline, fluid restriction, drugs (demeclocycline and vaptans) and increasing intake of solutes like urea/protein. Treatment decision is based on multiple factors like severity and symptoms of hyponatremia, onset of hyponatremia, underlying disease, and associated illness. Rate of correction and overcorrection are important factors to consider.
The decision to administer normal saline or hypertonic saline to patient with hyponatremia is quite clear and easy to practice. Except the use of saline and vaptans, rest of the treatment options are infrequently practiced, sometimes difficult to apply in critically ill patients especially with regard to fluid restriction.
Management of the hyponatremia should ensure patient management rather than simply looking at the sodium level. If hyponatremia is serious and symptomatic, it is life-threatening. In this situation, the first line of treatment will be prompt intravenous infusion of hypertonic saline.
For patients with reduced circulating volume, extracellular volume should be replaced with intravenous infusion of 0.9% saline. If the cause is apparent, reversing it may lead to correction as restricting water intake in psychogenic polydipsia, giving glucocorticoid/thyroid replacement in deficient, stopping hypotonic fluids or medications like selective serotonin reuptake inhibitors, nonsteroidal anti-inflammatory drugs, thiazides or desmopressin and optimization of Congestive heart failure (CHF), hepatic or renal failure.
For patients with the syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH), which constitutes about 40% of hyponatremia cases and with moderate or profound hyponatremia, first-line treatment is fluid restriction. Equal second-line treatments are increasing solute intake.
For moderate or profound hyponatremia, there is no recommendation for the use of lithium, demeclocycline, and even vasopressin receptor antagonist. Overcorrection is major reasons against vaptans. [1] There are not good outcome data either, with vaptans in form of improved survival or improved quality of life. [2] The lack of outcome data also applies to other treatments of hyponatremia.
There are a vast majority of hyponatremic patients in the Intensive Care Unit (ICU) who are neither volume deficient nor they have profound and symptomatic hyponatremia. There are also patients in critical care unit where it is difficult to implement fluid restriction.
